Eosinophils and eosinophilic immune dysfunction in health and disease.


Journal

European respiratory review : an official journal of the European Respiratory Society
ISSN: 1600-0617
Titre abrégé: Eur Respir Rev
Pays: England
ID NLM: 9111391

Informations de publication

Date de publication:
31 Mar 2022
Historique:
received: 30 06 2021
accepted: 22 10 2021
entrez: 27 1 2022
pubmed: 28 1 2022
medline: 29 1 2022
Statut: epublish

Résumé

The functions ascribed to eosinophils have classically been limited to host defence against certain parasitic infections and potentially deleterious effects in the setting of specific diseases that are associated with elevated eosinophil counts in blood and/or tissue. The ability to induce eosinophil depletion either experimentally in animal models or through targeted therapies in humans has extended our understanding of the roles played by eosinophils in health and homeostasis as well as in disease pathogenesis. When associated with human disease aetiology, the eosinophil takes on a pathogenic rather than a protective role. This maladaptive response, called "eosinophilic immune dysfunction" herein, appears central to exacerbation pathogenesis and disease control in severe asthma and may be involved in the aetiology of other eosinophil-related conditions ranging from organ-system-limited diseases such as phenotypic subsets of chronic obstructive pulmonary disease and chronic rhinosinusitis with nasal polyposis to more broadly systemic diseases such as eosinophilic granulomatosis with polyangiitis and hypereosinophilic syndrome. In this review, we describe the evidence supporting eosinophilic functions related to health and homeostasis and explore the contribution of eosinophilic immune dysfunction to human disease.

Identifiants

pubmed: 35082127
pii: 31/163/210150
doi: 10.1183/16000617.0150-2021
pmc: PMC9489126
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright ©The authors 2022.

Déclaration de conflit d'intérêts

Conflict of interest: D.J. Jackson has received consulting, speaker fees, and support to attend international congresses from AstraZeneca, GSK, Sanofi, Teva, BI, Novartis, Chiesi, and Napp. Conflict of interest: P. Akuthota has received consulting fees and research support from AstraZeneca, GlaxoSmithKline, and Regeneron; consulting fees from Advance Medical; grant support from the National Institutes of Health (US); royalties from UpToDate; and honoraria from Medscape/WebMD, AKH, Prime CME, Rockpointe, and Vindico. Conflict of interest: F. Roufosse has received consulting fees from AstraZeneca, GlaxoSmithKline, and Knopp Biosciences for drug development in hypereosinophilic syndromes and royalties from UpToDate.

Références

N Engl J Med. 2003 Mar 27;348(13):1201-14
pubmed: 12660384
Front Physiol. 2019 Dec 17;10:1514
pubmed: 31920718
Am J Respir Crit Care Med. 2019 Jan 15;199(2):158-170
pubmed: 30179583
N Engl J Med. 1975 May 29;292(22):1152-5
pubmed: 1124105
J Clin Invest. 2019 Mar 11;129(4):1419-1430
pubmed: 30855279
Respir Med. 2018 May;138:21-31
pubmed: 29724389
Lancet. 2016 Oct 29;388(10056):2128-2141
pubmed: 27609406
J Allergy Clin Immunol. 2020 Dec;146(6):1397-1405
pubmed: 32956756
J Immunol. 2009 Feb 1;182(3):1577-83
pubmed: 19155506
N Engl J Med. 2008 Mar 20;358(12):1215-28
pubmed: 18344568
N Engl J Med. 2017 Jun 22;376(25):2448-2458
pubmed: 28530840
Eur Respir J. 2014 Jul;44(1):239-41
pubmed: 24659543
Clin Rheumatol. 2020 Jun;39(6):1757-1764
pubmed: 31938882
J Allergy Clin Immunol Pract. 2021 Mar;9(3):1186-1193.e1
pubmed: 33065367
Immunology. 2019 Nov;158(3):194-205
pubmed: 31433857
N Engl J Med. 2019 Sep 12;381(11):1023-1034
pubmed: 31112385
Clin Rev Allergy Immunol. 2019 Oct;57(2):272-285
pubmed: 30903439
ERJ Open Res. 2020 Nov 10;6(4):
pubmed: 33263051
Cell Mol Immunol. 2019 Mar;16(3):225-235
pubmed: 30792500
Lancet Respir Med. 2015 Jun;3(6):435-42
pubmed: 25878028
J Clin Invest. 1975 Oct;56(4):870-9
pubmed: 1099120
Am J Rhinol Allergy. 2014 May-Jun;28(3):260-4
pubmed: 24980239
Annu Rev Immunol. 2021 Apr 26;39:719-757
pubmed: 33646859
Arthritis Rheum. 1990 Aug;33(8):1094-100
pubmed: 2202307
Eur Respir J. 2011 Sep;38(3):567-74
pubmed: 21233265
Lancet Respir Med. 2020 Feb;8(2):158-170
pubmed: 31575508
Chest. 2021 Feb;159(2):496-506
pubmed: 32882249
Arthritis Rheumatol. 2021 Sep;73(9):1683-1693
pubmed: 33750029
N Engl J Med. 2009 Mar 5;360(10):985-93
pubmed: 19264687
Respir Res. 2019 Jan 18;20(1):14
pubmed: 30658649
J Allergy Clin Immunol. 2017 Oct;140(4):1024-1031.e14
pubmed: 28687232
J Allergy Clin Immunol. 2020 Jun;145(6):1713-1715
pubmed: 32084443
N Engl J Med. 2014 Sep 25;371(13):1198-207
pubmed: 25199059
J Asthma Allergy. 2018 Aug 29;11:193-204
pubmed: 30214247
Lancet. 2003 Feb 15;361(9357):587-94
pubmed: 12598156
Infect Immun. 2019 Sep 19;87(10):
pubmed: 31285249
Allergy. 2013 Jul;68(7):829-35
pubmed: 23742015
Drug Saf. 2020 May;43(5):409-425
pubmed: 32242310
Am J Pathol. 1951 Mar-Apr;27(2):277-301
pubmed: 14819261
Lancet. 1958 Dec 13;2(7059):1245-7
pubmed: 13612182
Eur J Intern Med. 2015 Sep;26(7):545-53
pubmed: 25971154
Ann Allergy Asthma Immunol. 2021 Apr;126(4):438-440
pubmed: 33453381
Am J Respir Crit Care Med. 2014 Dec 15;190(12):1373-82
pubmed: 25350863
J Allergy Clin Immunol. 2010 Oct;126(4):828-835.e3
pubmed: 20810155
J Exp Med. 2002 Jun 3;195(11):1387-95
pubmed: 12045237
Biomed Res Int. 2018 Jan 28;2018:9095275
pubmed: 29619379
J Allergy Clin Immunol. 2018 Jul;142(1):24-31.e2
pubmed: 29859203
J Clin Invest. 2018 Mar 1;128(3):997-1009
pubmed: 29400693
Lancet Respir Med. 2021 Oct;9(10):1141-1153
pubmed: 33872587
N Engl J Med. 2014 Sep 25;371(13):1189-97
pubmed: 25199060
J Investig Allergol Clin Immunol. 2018;28(5):289-304
pubmed: 30059011
Ann Allergy Asthma Immunol. 2020 Sep;125(3):357-359.e1
pubmed: 32553608
J Asthma. 2021 Apr;58(4):514-522
pubmed: 31859541
Int J Chron Obstruct Pulmon Dis. 2021 Jun 16;16:1755-1770
pubmed: 34163157
J Allergy Clin Immunol Pract. 2019 Nov - Dec;7(8):2812-2820.e3
pubmed: 31128376
Adv Ther. 2020 Feb;37(2):718-729
pubmed: 31836949
Lancet Respir Med. 2019 Jan;7(1):46-59
pubmed: 30416083
Science. 2004 Sep 17;305(5691):1773-6
pubmed: 15375267
Annu Rev Pathol. 2020 Jan 24;15:179-209
pubmed: 31977298
Eur Respir J. 2020 May 7;55(5):
pubmed: 32060061
Blood. 2006 Oct 1;108(7):2420-7
pubmed: 16772607
Lancet Respir Med. 2015 May;3(5):355-66
pubmed: 25736990
ERJ Open Res. 2020 Nov 02;6(4):
pubmed: 33257916
Ann Allergy Asthma Immunol. 2020 Mar;124(3):233-239
pubmed: 31862435
Respir Med. 2018 Aug;141:56-63
pubmed: 30053973
Science. 2019 May 24;364(6442):
pubmed: 31123109
J Autoimmun. 2014 Feb-Mar;48-49:99-103
pubmed: 24530234
Clin Ther. 2016 Sep;38(9):2058-2070.e1
pubmed: 27553751
J Allergy Clin Immunol. 2010 Jun;125(6):1336-43
pubmed: 20513524
Nat Med. 2013 Aug;19(8):977-9
pubmed: 23921745
Lancet. 2016 Oct 29;388(10056):2115-2127
pubmed: 27609408
Laryngoscope. 2004 Nov;114(11):1895-905
pubmed: 15510011
J Clin Med. 2020 Nov 30;9(12):
pubmed: 33265990
Lancet Respir Med. 2015 Nov;3(11):849-58
pubmed: 26493938
Lancet Respir Med. 2021 Mar;9(3):260-274
pubmed: 33357499
N Engl J Med. 2017 May 18;376(20):1921-1932
pubmed: 28514601
Chest. 2020 Apr;157(4):790-804
pubmed: 31785254
N Engl J Med. 1990 Oct 11;323(15):1033-9
pubmed: 2215562
Respir Res. 2018 Jun 1;19(1):108
pubmed: 29859068
J Asthma. 2021 Sep;58(9):1270-1272
pubmed: 32519921
J Allergy Clin Immunol. 2018 Jan;141(1):110-116.e7
pubmed: 28456623
J Allergy Clin Immunol Pract. 2018 Sep - Oct;6(5):1518-1527.e5
pubmed: 29751154
Arthritis Rheum. 2013 Jan;65(1):1-11
pubmed: 23045170
Front Med (Lausanne). 2018 Apr 06;5:49
pubmed: 29682504
N Engl J Med. 2019 Apr 4;380(14):1336-1346
pubmed: 30943337
Expert Rev Hematol. 2012 Jun;5(3):275-89; quiz 290
pubmed: 22780208
Lancet Respir Med. 2018 Feb;6(2):117-126
pubmed: 29331313
Allergy. 2021 Jul;76(7):2238-2241
pubmed: 33432682
Allergy Asthma Proc. 2021 Mar 21;42(2):e55-e57
pubmed: 33536114
N Engl J Med. 2017 Oct 26;377(17):1613-1629
pubmed: 28893134
Allergy. 2021 Feb;76(2):471-482
pubmed: 32562554
Lancet. 2002 Nov 30;360(9347):1715-21
pubmed: 12480423
Ann Allergy Asthma Immunol. 2021 Jun;126(6):696-701.e1
pubmed: 33548468
PLoS One. 2019 Sep 6;14(9):e0217807
pubmed: 31490928
Immune Netw. 2020 Jun 23;20(3):e24
pubmed: 32655972
Expert Rev Clin Immunol. 2020 Jan;16(1):51-61
pubmed: 31762336

Auteurs

David J Jackson (DJ)

Guy's Severe Asthma Centre, Guy's & St Thomas' NHS Trust, London, UK david.jackson@gstt.nhs.uk.
School of Immunology & Microbial Sciences, King's College London, London, UK.

Praveen Akuthota (P)

Division of Pulmonary, Critical Care, and Sleep Medicine, Dept of Medicine, University of California, San Diego, La Jolla, CA, USA.

Florence Roufosse (F)

Médecine Interne, Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH